COVID‐19 patients benefit from early antiviral treatment: A comparative, retrospective study

The outbreak of COVID‐19, caused by severe acute respiratory syndrome coronavirus 2, started in December 2019, Wuhan, China. We aimed to figure out the time‐point and duration of using antiviral drugs for receiving the maximal effects in patients with COVID‐19. In this study, we enrolled 129 confirm...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Med Virol
Prif Awduron: Yu, Ting, Tian, Chunxia, Chu, Si, Zhou, Haifeng, Zhang, Zili, Luo, Shanshan, Hu, Desheng, Fan, Heng
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Research Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300891/
https://ncbi.nlm.nih.gov/pubmed/32492205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26129
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg